Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Increased role for PET imaging could improve cancer care


A limitation of current cancer care is the difficulty of quickly assessing how well a therapy is working. However, expanding the use of existing positron emission tomography (PET) technology can provide early and accurate assessment of a tumor’s response to a particular therapy allowing physicians to better tailor a patient’s treatment, according to Malik Juweid, M.D., associate professor of radiology at the University of Iowa Roy J. and Lucille A. Carver College of Medicine.

Writing in the Feb. 2 issue of the New England Journal of Medicine, Juweid and co-author Bruce Cheson, M.D., of the Lombardi Comprehensive Cancer Center at Georgetown University Hospital, outline the advantages and limitations of PET imaging in assessing cancer therapy and suggest that increasing the role of PET imaging has the potential to further improve cancer care management.

PET is a non-invasive imaging technique that uses radioactivity emitted from injected tracer chemicals to measure and image biological activity. The most commonly used PET radiotracer is fluorodeoxyglucose (FDG), a radiolabeled form of glucose, which is consumed more avidly by tumors than by normal tissue.

In fact, Juweid’s work already has led to changes in how PET is used in cancer care.

In a study published in the Journal of Clinical Oncology in July 2005, Juweid and colleagues showed that adding FDG-PET to the standard computer tomography (CT)-based assessment criteria made the predictions of treatment outcome much more accurate for aggressive non-Hodgkin’s lymphoma. Based on this study, the new internationally accepted criteria will include PET as an essential part of the assessment and management of lymphoma.

"Basically, about half of patients were called partial or incomplete responders because CT found a residual mass after treatment despite lack of any other evidence of disease," Juweid said. "However, PET showed that the residual mass was scar tissue rather than viable tumor in more than half of these patients. These patients were, therefore, reassigned as complete responders, and we found that they did just as well as patients who had been given the ’all clear’ from the CT scan."

The study showed that if PET is negative, patients can be safely observed without biopsy, and patients and physicians can be much more confidant that the patient will remain progression free. However, if a PET scan is positive and the findings are confirmed by a biopsy, patients can move more quickly to necessary salvage therapy.

Juweid, who also is a member of the UI Holden Comprehensive Cancer Center, adds that PET is currently a routine part of response assessment for patients being treated for aggressive lymphoma at UI Hospitals and Clinics.

PET is currently approved by the Centers for Medicare and Medicaid Services (CMS) for restaging in breast, colorectal, esophageal, head and neck, and non-small-cell lung cancers, as well as melanoma and lymphoma. Restaging means checking whether there is residual or recurrent tumor after completion of treatment and, if so, determining its extent.

Although PET is extremely useful and is routinely used for restaging in many cancers, Juweid sees an even more important role for PET as a tool to enable physicians to monitor tumor response during treatment and potentially to tailor the treatment based on the PET results.

Currently, the only CMS-approved clinical use for PET in monitoring response to treatment is for breast cancer. However, Juweid says that many studies are suggesting that PET could also be useful in monitoring the effect of treatment in other cancers.

"For PET to be approved for monitoring treatment, clinical trials will need to demonstrate that using PET to tailor treatment has a beneficial effect in terms of patient outcomes," Juweid said.

Although benefit usually means improved patient outcomes, Juweid argues that other outcomes also could be viewed as beneficial to the patient. For example, stopping chemotherapy when a PET scan shows the treatment is not working would spare the patient from toxic side effects and might also prevent a tumor from becoming resistant to chemotherapy before a more potent treatment can be tried. Alternative treatment options would be pursued for these patients.

Juweid also suggests that another way to capitalize on PET’s ability to detect tumor response early will be using PET images to establish end points in trials aimed at testing cancer therapies. This approach could shorten the time required to evaluate drugs or therapies.

The UI has long-standing program in PET imaging. UI Hospitals and Clinics is equipped with a PET scanner for both clinical and research purposes, and another devoted purely for research, and a PET-CT scanner, which combines the spatial information obtained in a CT scan with the metabolic information from PET. There also are plans to purchase a second PET-CT scanner.

Jennifer Brown | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Advanced analysis of brain structure shape may track progression to Alzheimer's disease
26.10.2016 | Massachusetts General Hospital

nachricht Indian roadside refuse fires produce toxic rainbow
26.10.2016 | Duke University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Etching Microstructures with Lasers

Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.

This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...

Im Focus: Light-driven atomic rotations excite magnetic waves

Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion

Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

How nanoscience will improve our health and lives in the coming years

27.10.2016 | Materials Sciences

OU-led team discovers rare, newborn tri-star system using ALMA

27.10.2016 | Physics and Astronomy

'Neighbor maps' reveal the genome's 3-D shape

27.10.2016 | Life Sciences

More VideoLinks >>>